Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia

Schneider H, Faschingbauer F, Schuepbach-Mallepell S, Koerber I, Wohlfart S, Dick A, Wahlbuhl M, Kowalczyk-Quintas C, Vigolo M, Kirby N, Tannert C, Rompel O, Rascher W, Beckmann M, Schneider P (2018)


Publication Type: Journal article

Publication year: 2018

Journal

Book Volume: 378

Pages Range: 1604-1610

Journal Issue: 17

DOI: 10.1056/NEJMoa1714322

Abstract

Genetic deficiency of ectodysplasin A (EDA) causes X-linked hypohidrotic ectodermal dysplasia (XLHED), in which the development of sweat glands is irreversibly impaired, an condition that can lead to life-threatening hyperthermia. We observed normal development of mouse fetuses with Eda mutations after they had been exposed in utero to a recombinant protein that includes the receptor-binding domain of EDA. We administered this protein intraamniotically to two affected human twins at gestational weeks 26 and 31 and to a single affected human fetus at gestational week 26; the infants, born in week 33 (twins) and week 39 (singleton), were able to sweat normally, and XLHED-related illness had not developed by 14 to 22 months of age. (Funded by Edimer Pharmaceuticals and others.).

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Schneider, H., Faschingbauer, F., Schuepbach-Mallepell, S., Koerber, I., Wohlfart, S., Dick, A.,... Schneider, P. (2018). Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia. New England Journal of Medicine, 378(17), 1604-1610. https://dx.doi.org/10.1056/NEJMoa1714322

MLA:

Schneider, Holm, et al. "Prenatal Correction of X-Linked Hypohidrotic Ectodermal Dysplasia." New England Journal of Medicine 378.17 (2018): 1604-1610.

BibTeX: Download